🟢 Krystal Biotech is trading 4.57% up in pre-market amid broader risk-on sentiment

Krystal Biotech is trading 4.57% up at $354.22, with the move appearing aligned with broader risk-on sentiment.

• It closed at $338.75 on September 17, 2026.
• No fresh company-specific announcement was identified for September 18, 2026.
• Nasdaq futures and the S&P 500 were higher, while a dovish interpretation of the Bank of Japan’s rate hike supported global equities. Recent positive Q2 results and pipeline commentary did not directly explain the move.